16 June 2020 : Clinical Research
Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial
Wei Yao1ABE, Lixin Wang2AB*, Qing Chen1BC, Fang Wang1CD, Nana Feng1EFDOI: 10.12659/MSM.919977
Med Sci Monit 2020; 26:e919977
Table 1 Comparison of baseline data between the 2 groups.
| ARB group (98 patients) | Control group (96 patients) | P | |
|---|---|---|---|
| Age | 53.1±6.2 | 55.1±8.3 | 0.347 |
| Female sex | 74 | 71 | 0.804 |
| History of hypertension | 80 | 76 | 0.665 |
| Smoking history | 57 | 62 | 0.359 |
| Coronary heart disease | 35 | 42 | 0.253 |
| Glycated hemoglobin | 6.1±1.2 | 6.0±1.5 | 0.725 |
| Clinical Fontaine stage III | 68 | 69 | 0.704 |
| Stent length >15 cm | 20 | 15 | 0.386 |